Senior insider sale
Chief Medical Officer at OCULAR THERAPEUTIX, INC — senior position signals high conviction
$1.55M
194.76K shares
OZDEN RABIA GURSES plans to sell 194.76K shares of OCULAR THERAPEUTIX, INC valued at approximately $1.55M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Exercise of options under a registered plan
Cash
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/27/2024 | Exercise of options under a registered plan Cash | 18.33K | — |
| Total | 18.33K | ||
Completed
Units to sell
10K
Market value
$89.0K
Units to sell
15K
Market value
$127.5K
Units to sell
55.55K
Market value
$443.9K
Units to sell
8.25K
Market value
$70.3K
Units to sell
20.75K
Market value
$171.2K
Units to sell
28.44K
Market value
$229.2K
Units to sell
38.44K
Market value
$251.9K
Planned — Approximate Date
Units to sell
18.33K
Market value
$165.0K
Units
194.76K
Value
$1.55M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/21/2024 | 10K | $89.0K | — | Completed |
8/7/2024 | 15K | $127.5K | — | Completed |
7/17/2024 | 55.55K | $443.9K | — | Completed |
7/16/2024 | 8.25K | $70.3K | — | Completed |
7/15/2024 | 20.75K | $171.2K | — | Completed |
7/12/2024 | 28.44K | $229.2K | — | Completed |
7/9/2024 | 38.44K | $251.9K | — | Completed |
| Planned — Approximate Date | ||||
8/27/2024 | 18.33K | $165.0K | NASDAQ | Planned |
| Total | 194.76K | $1.55M | ||